111, Inc. (YI)
Market Cap | 75.38M |
Revenue (ttm) | 2.09B |
Net Income (ttm) | -36.39M |
Shares Out | 85.66M |
EPS (ttm) | -0.43 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 179,040 |
Open | 0.740 |
Previous Close | 0.736 |
Day's Range | 0.740 - 0.898 |
52-Week Range | 0.550 - 1.850 |
Beta | 0.38 |
Analysts | n/a |
Price Target | n/a |
Earnings Date | Nov 27, 2024 |
About YI
111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates in two segments, B2C and B2B. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers. It offers prescription and over-the counter drugs, including western and traditional Chinese medicines; nutritio... [Read more]
Financial Performance
In 2023, 111, Inc.'s revenue was 14.95 billion, an increase of 10.59% compared to the previous year's 13.52 billion. Losses were -392.69 million, -5.80% less than in 2022.
Financial numbers in CNY Financial StatementsNews
111, Inc. (YI) Q3 2024 Earnings Call Transcript
111, Inc. (NASDAQ:YI) Q3 2024 Results Conference Call November 27, 2024 7:30 AM ET Company Participants Dr. Gang Yu - Co-Founder and Executive Chairman Junling Liu - Co-Founder, Chairman and Chief Ex...
111, Inc. Announces Third Quarter 2024 Unaudited Financial Results
Maintained Operational Profitability for the Third Consecutive Quarter Operating Expenses as a Percentage of Revenues Decreased 160 Basis Points YoY Held Positive Operating Cash Flow for Three Consecu...
111, Inc. to Participate in Fireside Chat with Water Tower Research on December 6, 2024
SHANGHAI , Nov. 21, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare indust...
111 Reschedules Third Quarter 2024 Unaudited Financial Results Announcement to November 27, 2024 - Conference Call to Follow
SHANGHAI , Nov. 4, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industr...
111, Inc. Announces Change to Board of Directors
SHANGHAI , Nov. 4, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industr...
111, Inc. to Participate in Fireside Chat with Water Tower Research on October 30, 2024
SHANGHAI , Oct. 22, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare indust...
111 to Announce Third Quarter 2024 Unaudited Financial Results on November 28, 2024 - Conference Call to Follow
SHANGHAI , Oct. 18, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare indust...
111 Inc. Expands National Supply Chain Network with New Fulfillment Centers across South and Central China
SHANGHAI , Oct. 10, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare indust...
111, Inc. Announces Receipt of Notification from Nasdaq
SHANGHAI , Sept. 27, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare indus...
Synthetic Fiber Market Size is Anticipated to Reach USD 111.9 billion, Advancing at a CAGR of 4.8% by 2034: Transparency Market Research Inc.
Surge in demand for synthetic fibers in the medical sector for manufacturing surgical garments, wound dressings, and medical textiles. Surge in demand for synthetic fibers in the medical sector for ma...
111 Inc. Announces Its Co-founders' Strategic Share Purchase and Highlights Continued Growth and Innovation
SHANGHAI , Sept. 13, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare indus...
111, Inc. (YI) Q2 2024 Earnings Call Transcript
111, Inc. (NASDAQ:YI) Q2 2024 Earnings Conference Call August 29, 2024 7:30 AM ET Company Participants Junling Liu - Co-Founder, Chairman and CEO Luke Chen - CFO, 111's Major Subsidiary Conference Ca...
111, Inc. Announces Second Quarter 2024 Unaudited Financial Results
Maintained Operational Profitability for the Second Consecutive Quarter Operating Expenses as a Percentage of Revenues Decreased 120 Basis Points YoY Held Positive Operating Cash Flow for Two Consecut...
111, Inc. to Participate in Fireside Chat with Water Tower Research on September 5, 2024
SHANGHAI , Aug. 27, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare indust...
111 to Announce Second Quarter 2024 Unaudited Financial Results on August 29, 2024 - Conference Call to Follow
SHANGHAI , July 29, 2024 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare indust...
111 Announces Appointment of New Auditor
SHANGHAI , July 19, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare indust...
111, Inc. to Participate in Fireside Chat with Water Tower Research on July 18, 2024
SHANGHAI July 17, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry...
111, Inc., Scrianen Announce Strategic Direct Supply Partnership to Expand Nationwide Reach and Improve Drug Accessibility
SHANGHAI , June 11, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare indust...
111, Inc. (YI) Q1 2024 Earnings Call Transcript
111, Inc. (NASDAQ:YI) Q1 2024 Earnings Conference Call May 23, 2024 7:30 AM ET Company Participants Junling Liu - Co-Founder, Chairman and CEO Luke Chen - CFO, 111's Major Subsidiary Haihui Wang - CO...
111, Inc. Announces First Quarter 2024 Unaudited Financial Results
Turned to Quarterly Operational Profitability for the First Time Operating Expenses as a Percentage of Revenues Decreased 120 Basis Points YoY to 5.8% Achieved Positive Operating Cash Flow SHANGHAI , ...
111 to Announce First Quarter 2024 Unaudited Financial Results on May 23, 2024 - Conference Call to Follow
SHANGHAI , April 30, 2024 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine a...
111, Inc. (YI) Q4 2023 Earnings Call Transcript
111, Inc. (YI) Q4 2023 Earnings Call Transcript
111, Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results
SHANGHAI , March 21, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine a...
111 to Announce Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results- Conference Call to Follow
SHANGHAI , March 1, 2024 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine an...
111 Announces Receipt of Withdrawal of Going Private Proposal
SHANGHAI , Feb. 27, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine an...